O
TARA icon

OrbiMed’s Protara Therapeutics TARA Stock Holding History

OrbiMed’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-772,584
Closed -$1.29M – 133
2023
Q3 		$1.29M Hold
772,584
– – 0.03% 118
2023
Q2 		$1.85M Sell
772,584
-20,974
-3% -$62.3K 0.03% 117
2023
Q1 		$2.48M Sell
793,558
-37,083
-4% -$123K 0.05% 111
2022
Q4 		$2.23M Hold
830,641
– – 0.04% 102
2022
Q3 		$2.46K Hold
830,641
– – 0.05% 119
2022
Q2 		$2.43K Hold
830,641
– – 0.04% 127
2022
Q1 		$4.25M Hold
830,641
– – 0.07% 124
2021
Q4 		$5.61M Buy
830,641
+380,641
+85% +$2.62M 0.07% 131
2021
Q3 		$3.11M Hold
450,000
– – 0.03% 163
2021
Q2 		$4.38M Hold
450,000
– – 0.04% 150
2021
Q1 		$7.08M Hold
450,000
– – 0.07% 132
2020
Q4 		$10.9M Hold
450,000
– – 0.1% 121
2020
Q3 		$7.57M Buy
+450,000
New +$10.4M 0.1% 116

Other funds holding TARA

OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $699M AUM 600.17% 1-Year Est. Return
PFMU
Privium Fund Management (UK) London, United Kingdom $197M AUM 0.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return